Breaking News

Yesterday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	Endo files Chapter 11 bankruptcy, enters agreement with debt holders » 09:30 08/17/22 08/17 09:30 08/17/22 09:30 ENDP Endo / + Endo International… Endo International announced that it has entered into a restructuring support agreement with holders of more than a majority of Endo's first lien debt on a sale transaction that would reduce "outstanding indebtedness, address remaining opioid and other litigation-related claims, and best position Endo for the future." Under the RSA, the debtholder group has committed to providing total purchase consideration of approximately $6B in the form of a credit bid, plus assumption of certain liabilities, for substantially all of the company's assets. The transaction contemplates that the purchaser will: Offer employment to all of Endo's active team members; Establish voluntary trusts, to be funded with $550M over 10 years, whereby future proceeds will be set aside for certain opioid claims; and have net funded leverage in an amount no greater than 4.5 times. This "stalking horse" bid will be subject to higher or otherwise better offers, the company said in a statement. To facilitate the sale process and provide an appropriate forum for bringing closure to opioid-related and other uncertainties, Endo and certain of its subsidiaries initiated voluntary prearranged Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of New York. Endo's India-based entities are not part of the Chapter 11 proceedings. The company expects to file recognition proceedings in Canada, the United Kingdom, and Australia. Shares of Endo are up 15% to 43c in premarket trading. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ENDP Endo / + 08/15/22 Paulson buys VMware, exits DiDi in Q2 08/09/22 Endo expects pre-arranged filing under Chapter 11 'imminently' 07/26/22 Buxton Helmsley sends letter to Endo directors relating to financial disclosures 07/18/22 Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer ENDP Endo / + 05/09/22 BMO Capital Endo price target lowered to $2 from $4 at BMO Capital 05/09/22 Barclays Endo price target lowered to $1 from $2 at Barclays 05/06/22 Piper Sandler Piper downgrades Endo to sell, says 'going from bad to worse' 05/06/22 Piper Sandler Endo downgraded to Underweight from Neutral at Piper Sandler ENDP Endo / + 08/09/22 Endo reports Q2 adjusted EPS (3c), consensus (14c) 05/05/22 Endo sees Q2 adjusted cont ops EPS (17c)-(15c), consensus 48c 05/05/22 Endo reports Q1 adjusted EPS 66c, consensus 44c 02/28/22 Endo sees Q1 EPS 35c-45c, consensus 48c ENDP Endo / + 07/12/22 Without an opioid deal, Endo moving toward bankruptcy filing, WSJ reports 06/30/22 Endo mulls bond decision amid bankruptcy considerations, Bloomberg reports ENDP Endo / + 07/12/22 What You Missed On Wall Street On Tuesday 07/01/22 Fly Intel: Pre-market Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning ENDP Endo / + 08/12/22 Largest borrow rate increases among liquid names 08/11/22 Largest borrow rate increases among liquid names 08/09/22 Endo options imply 43.5% move in share price post-earnings 08/08/22 Endo options imply 25.5% move in share price post-earnings

Monday
Hot Stocks	Paulson buys VMware, exits DiDi in Q2 » 17:16 08/15/22 08/15 17:16 08/15/22 17:16 VMW VMware $122.42 / +0.46 (+0.38%) , IS ironSource $4.45 / +0.43 (+10.70%) , GLD SPDR Gold Shares $165.73 / -2.14 (-1.27%) , DIDIY Didi Global $2.31 / + (+0.00%) , XOM Exxon Mobil $92.32 / -1.68 (-1.79%) , OIH Oil Services Holders Trust $233.06 / -9.82 (-4.04%) , TIMB Tim SA $12.24 / -0.305 (-2.43%) , HZNP Horizon Therapeutics $64.90 / -2.58 (-3.82%) , BHC Bausch Health $6.28 / +0.265 (+4.41%) , ENDP Endo / + , OXY Occidental Petroleum $64.34 / -1.37 (-2.08%) , PCRX Pacira $57.77 / +0.4 (+0.70%) , NMRK Newmark $11.25 / +0.17 (+1.53%) , BSIG BrightSphere $20.13 / +0.055 (+0.27%) , KWEB KraneShares CSI China Internet ETF $28.84 / +0.21 (+0.73%) John Paulson's… John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of June 30, 2022. The fund's five new buys during the second quarter included, by size of position, VMware (VMW) and IronSource (IS). Paulson exited six positions during the quarter, including by size of previous position SPDR Gold Shares (GLD), DiDi (DIDIY), Exxon Mobil (XOM), VanEck Oil Services ETF (OIH), and TIM SA (TIMB). The fund increased its stake in two holdings, namely Horizon Therapeutics (HZNP) and Bausch Health (BHC). Paulson reduced its stake in four holdings, including by size of previous position Endo (ENDP), Occidental (OXY), Pacira Biosciences (PCRX) and Newmark (NMRK). The fund's top holdings as of June 30, in order of size, were Horizon Therapeutics, Bausch Health, BrightSphere (BSIG), Occidental, and KraneShares CSI China Internet ETF (KWEB). ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options Technical Analysis XOM VMW TIMB PCRX OXY NMRK IS HZNP GLD ENDP DIDIY BHC XOM Exxon Mobil $92.32 / -1.68 (-1.79%) 08/01/22 TechnipFMC awarded contract for energy project in Guyana 07/29/22 Exxon Mobil reports Q2 free cash flow $16.9B 07/29/22 Exxon Mobil reports Q2 cash flow from operating activities of $20B 07/28/22 Wex plans to acquire Exxon Mobil Business Card program VMW VMware $122.42 / +0.46 (+0.38%) 07/27/22 HCL, VMware launch dedicated VMware business unit 06/23/22 Rackspace announces selection by VMware as strategic SASE deployment partner 05/26/22 Broadcom deal for VMware provides for 'go-shop' provision 05/26/22 Broadcom to buy VMware for about $61B in cash and stock or $138.23 per share TIMB Tim SA $12.24 / -0.305 (-2.43%) 04/20/22 TIM SA trading resumes 04/20/22 Tim SA completes acquisition of Oi's mobile operation assets 04/20/22 TIM SA trading halted, news pending PCRX Pacira $57.77 / +0.4 (+0.70%) 08/10/22 Pacira reports preliminary net product sales of $50.2M for July 08/09/22 Pacira, NFLA team up to educate athletes on non-opioid pain management 08/03/22 Pacira sees 2022 R&D expense $75M-$85M 06/16/22 Pacira, National Safety Council partner to launch Connect2Prevent program OXY Occidental Petroleum $64.34 / -1.37 (-2.08%) 08/15/22 Berkshire Hathaway exits Verizon, cuts GM in Q2 08/15/22 David Tepper's Appaloosa buys Salesforce, exits Nordstrom in Q2 08/08/22 Berkshire Hathaway increases Occidental Petroleum stake by $390.7M 08/03/22 Occidental says Permian CapEx hike to be mitigated by other assets NMRK Newmark $11.25 / +0.17 (+1.53%) 05/03/22 Newmark acquires Open Realty, terms not disclosed 04/07/22 Newmark acquires McCall & Almy, terms not disclosed 04/04/22 Newmark acquires real estate advisory firm BH2, terms not disclosed IS ironSource $4.45 / +0.43 (+10.70%) 08/15/22 Tiger Global buys Alphabet Class A, exits Zoom Video in Q2 08/15/22 ironSource rises 11.7% 08/15/22 ironSource rises 17.1% 08/15/22 ironSource comments on Unity rejection of AppLovin proposal HZNP Horizon Therapeutics $64.90 / -2.58 (-3.82%) 08/15/22 Horizon Therapeutics and Q32 Bio to collaborate in autoimmune diseases 07/08/22 Horizon Therapeutics announces FDA approval of Krystexxa sBLA 06/24/22 Horizon says new analysis finds Uplizna effective among EU populations 06/15/22 Horizon Therapeutics submits regulatory filing to ANVISA for Uplizna GLD SPDR Gold Shares $165.73 / -2.14 (-1.27%) 05/23/22 SPDR Gold Shares holdings rise from 1,063.4MT to 1,068.1MT 05/19/22 SPDR Gold Shares holdings rise from 1,049.2MT to 1,056.2MT 05/16/22 David Einhorn's Greenlight adds Southwestern, exits Sonos in Q1 05/16/22 Paulson exits Cerner, boosts Didi in Q1 ENDP Endo / + 08/09/22 Endo expects pre-arranged filing under Chapter 11 'imminently' 07/26/22 Buxton Helmsley sends letter to Endo directors relating to financial disclosures 07/18/22 Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer 07/15/22 Quoin Pharmaceuticals, Endo enter into exclusive distribution, supply agreement DIDIY Didi Global $2.31 / + (+0.00%) 08/12/22 Soros adds Biohaven, exits Lucid in Q2 06/13/22 DiDi Global will now trade on OTC Pink Current market under symbol 'DIDIY' BHC Bausch Health $6.28 / +0.265 (+4.41%) 08/10/22 Bausch Health to appeal XIFAXAN patent decision 08/01/22 Bausch Health credit cut at S&P on 'much more challenging' prospects 07/28/22 Bausch Health trading resumes 07/28/22 Bausch Health to appeal expected court decision on certain Xifaxan patents VMW IS GLD DIDIY XOM OIH TIMB HZNP BHC ENDP OXY PCRX NMRK BSIG KWEB VMW VMware $122.42 / +0.46 (+0.38%) 07/06/22 Raymond James VMware downgraded to Market Perform from Outperform at Raymond James 05/31/22 Deutsche Bank VMware price target raised to $142.50 from $135 at Deutsche Bank 05/27/22 RBC Capital VMware downgraded to Sector Perform from Outperform at RBC Capital 05/27/22 Mizuho Broadcom price target raised to $725 from $700 at Mizuho IS ironSource $4.45 / +0.43 (+10.70%) 08/11/22 Credit Suisse ironSource downgraded to Neutral from Outperform at Credit Suisse 08/10/22 Citi AppLovin bid for Unity faces 'several challenges,' says Citi 08/10/22 Barclays Unity price target raised to $49 from $35 at Barclays 08/09/22 Stifel Unity price target raised to $60 at Stifel after AppLovin proposal GLD SPDR Gold Shares $165.73 / -2.14 (-1.27%) DIDIY Didi Global $2.31 / + (+0.00%) XOM Exxon Mobil $92.32 / -1.68 (-1.79%) 08/10/22 Credit Suisse Exxon Mobil assumed with an Outperform at Credit Suisse 08/01/22 BofA Exxon Mobil price target raised to $123 from $120 at BofA 07/28/22 Stifel NextDecade upgraded to Hold from Sell at Stifel 07/20/22 HSBC Exxon Mobil price target raised to $97.50 from $92.50 at HSBC OIH Oil Services Holders Trust $233.06 / -9.82 (-4.04%) TIMB Tim SA $12.24 / -0.305 (-2.43%) 06/30/22 Barclays Tim SA price target raised to $17 from $16 at Barclays 04/18/22 Citi Tim SA initiated with a Buy at Citi 02/01/22 Barclays Tim SA price target lowered to $16 from $17 at Barclays 11/10/21 UBS Tim SA upgraded to Buy from Neutral at UBS HZNP Horizon Therapeutics $64.90 / -2.58 (-3.82%) 08/04/22 BMO Capital Horizon Therapeutics price target lowered to $117 from $145 at BMO Capital 08/04/22 UBS Horizon Therapeutics downgraded to Neutral from Buy at UBS 08/04/22 SVB Securities Horizon Therapeutics downgraded to Market Perform from Outperform at SVB Securities 08/03/22 Stifel Horizon Therapeutics price target lowered to $138 from $140 at Stifel BHC Bausch Health $6.28 / +0.265 (+4.41%) 07/29/22 RBC Capital Bausch Health downgraded to Sector Perform from Outperform at RBC Capital 07/29/22 RBC Capital Bausch Health downgraded to Sector Perform from Outperform at RBC Capital 07/28/22 Truist Bausch Health downgraded to Hold from Buy at Truist 07/28/22 Stifel Stifel puts Bausch rating under review amid 'significant confusion' ENDP Endo / + 05/09/22 BMO Capital Endo price target lowered to $2 from $4 at BMO Capital 05/09/22 Barclays Endo price target lowered to $1 from $2 at Barclays 05/06/22 Piper Sandler Piper downgrades Endo to sell, says 'going from bad to worse' 05/06/22 Piper Sandler Endo downgraded to Underweight from Neutral at Piper Sandler OXY Occidental Petroleum $64.34 / -1.37 (-2.08%) 07/28/22 MKM Partners Climate bill contains 'strong benefit' to carbon capture E&Ps, says MKM 07/26/22 Barclays Occidental Petroleum price target lowered to $79 from $84 at Barclays 07/20/22 MKM Partners Occidental Petroleum assumed with a Neutral at MKM Partners 07/19/22 Truist Occidental Petroleum price target raised to $105 from $93 at Truist PCRX Pacira $57.77 / +0.4 (+0.70%) 07/21/22 Piper Sandler Pacira price target lowered to $80 from $84 at Piper Sandler 03/01/22 Northland Pacira price target raised to $67 from $61 at Northland 02/25/22 H.C. Wainwright Pacira price target raised to $90 from $86 at H.C. Wainwright 01/19/22 Barclays Pacira price target raised to $96 from $92 at Barclays NMRK Newmark $11.25 / +0.17 (+1.53%) 04/18/22 Piper Sandler Newmark downgraded to Neutral from Overweight at Piper Sandler 04/05/22 Goldman Sachs Newmark initiated with a Neutral at Goldman Sachs 03/10/22 Wolfe Research Newmark downgraded to Peer Perform from Outperform at Wolfe Research 03/10/22 Wolfe Research Newmark downgraded to Peer Perform from Outperform at Wolfe Research BSIG BrightSphere $20.13 / +0.055 (+0.27%) 04/08/22 Morgan Stanley BrightSphere price target lowered to $27 from $29 at Morgan Stanley 12/14/21 Morgan Stanley BrightSphere downgraded at Morgan Stanley on more balanced risk/reward 12/14/21 Morgan Stanley BrightSphere downgraded to Equal Weight from Overweight at Morgan Stanley 10/29/21 Keefe Bruyette BrightSphere downgraded to Market Perform from Outperform at Keefe Bruyette KWEB KraneShares CSI China Internet ETF $28.84 / +0.21 (+0.73%) 03/16/22 US Tiger China Internet sector upgraded to Outperform from Neutral at US Tiger XOM VMW PCRX OXY NMRK IS HZNP ENDP BSIG BHC XOM Exxon Mobil $92.32 / -1.68 (-1.79%) 07/29/22 Exxon Mobil reports Q2 adjusted EPS $4.14, consensus $3.74 07/28/22 Notable companies reporting before tomorrow's open 04/29/22 Exxon Mobil reports Q1 adjusted EPS $2.07, consensus $2.12 VMW VMware $122.42 / +0.46 (+0.38%) 05/26/22 VMware reports Q1 EPS $1.28, consensus $1.56 02/24/22 VMware sees FY23 EPS $6.97, consensus $7.29 02/24/22 VMware sees Q1 EPS $1.56, consensus $1.64 02/24/22 VMware reports Q4 adjusted EPS $2.02, consensus $1.97 PCRX Pacira $57.77 / +0.4 (+0.70%) 08/03/22 Pacira reports Q2 EPS 40c, consensus 88c 07/14/22 Pacira not providing 2022 revenue guidance 07/14/22 Pacira reports preliminary Q2 revenue $169.4M, consensus $174.91M 05/04/22 Pacira reports Q1 non-GAAP EPS 64c, consensus 83c OXY Occidental Petroleum $64.34 / -1.37 (-2.08%) 08/03/22 Occidental Petroleum sees Q3 total oil & gas production 1,140-1,170 Mboed 08/02/22 Occidental Petroleum reports Q2 EPS $3.16, consensus $3.02 05/10/22 Occidental Petroleum reports Q1 adjusted EPS $2.12, consensus $2.03 02/24/22 Occidental Petroleum reports Q4 adjusted EPS $1.48, consensus $1.10 NMRK Newmark $11.25 / +0.17 (+1.53%) 07/29/22 Newmark reaffirms FY22 revenue view $3.000B-$3.100B, consensus $3.06B 07/29/22 Newmark reports Q2 GAAP EPS 26c, consensus 36c 04/29/22 Newmark sees FY22 revenue $3.0B-$3.1B, consensus $3.16B 04/29/22 Newmark reports Q1 adjusted EPS 36c, consensus 25c IS ironSource $4.45 / +0.43 (+10.70%) 08/10/22 ironSource reports Q2 EPS 1c, consensus 2c 07/13/22 ironSource backs Q2, FY22 guidance 05/12/22 ironSource sees 2022 revenue $750M-$780M, consensus $810.88M 05/12/22 ironSource sees Q2 revenue $180M-$185M, consensus $194.23M HZNP Horizon Therapeutics $64.90 / -2.58 (-3.82%) 08/03/22 Horizon Therapeutics cuts FY22 revenue view to $3.53B-$3.6B from $3.9B-$4B 08/03/22 Horizon Therapeutics reports Q2 adjusted EPS $1.07, consensus $1.35 05/04/22 Horizon Therapeutics reports Q1 EPS $1.34, consensus $1.14 03/01/22 Horizon Therapeutics sees FY22 revenue $3.9B-$4B, consensus $3.91B ENDP Endo / + 08/09/22 Endo reports Q2 adjusted EPS (3c), consensus (14c) 05/05/22 Endo sees Q2 adjusted cont ops EPS (17c)-(15c), consensus 48c 05/05/22 Endo reports Q1 adjusted EPS 66c, consensus 44c 02/28/22 Endo sees Q1 EPS 35c-45c, consensus 48c BSIG BrightSphere $20.13 / +0.055 (+0.27%) 07/28/22 BrightSphere reports Q2 ENI EPS 41c, consensus 42c 05/05/22 BrightSphere reports Q1 EPS 52c, consensus 45c BHC Bausch Health $6.28 / +0.265 (+4.41%) 08/09/22 Bausch Health lowers FY22 revenue view to $8.05B-$8.22B from $8.25B-$8.40B 08/09/22 Bausch Health reports Q2 GAAP EPS (40c), consensus 89c 05/10/22 Bausch Health sees 2022 revenue $8.25B-$8.4B, consensus $8.57B 05/10/22 Bausch Health reports Q1 EPS (19c), consensus $1.29 XOM VMW OXY ENDP DIDIY BHC XOM Exxon Mobil $92.32 / -1.68 (-1.79%) 08/11/22 Nigerian president holds back on Exxon asset sale approval, Reuters says 08/03/22 OPEC+ answers diplomatic efforts with 'minuscule' output hike, Bloomberg says 08/02/22 OPEC+ sees slightly smaller oil market surplus in 2022, Reuters reports 07/06/22 OPEC Secretary-General Mohammad Barkindo dies, Bloomberg reports VMW VMware $122.42 / +0.46 (+0.38%) 06/23/22 Broadcom $69B VMware deal set for lengthy EU antitrust probe, FT says 05/24/22 Broadcom deal for VMware structured as 50/50 cash and stock split, CNBC says 05/23/22 Broadcom discussing paying $140 per share in cash, stock for VMware, WSJ says 05/23/22 Broadcom discussing paying $140 per share for VMware, WSJ says OXY Occidental Petroleum $64.34 / -1.37 (-2.08%) 03/26/22 Warren Buffett spending big again, good for stock, Barron's says 03/17/22 SEC rejects Occidental's move to throw out green investor resolution, FT reports 03/11/22 Colorado regulator denies Occidental's request to drill near homes, Reuters says 03/07/22 Berkshire Hathaway takes $5B stake in Occidental, CNBC reports ENDP Endo / + 07/12/22 Without an opioid deal, Endo moving toward bankruptcy filing, WSJ reports 06/30/22 Endo mulls bond decision amid bankruptcy considerations, Bloomberg reports DIDIY Didi Global $2.31 / + (+0.00%) 08/11/22 Didi-Li Auto JV files for bankruptcy, Reuters reports 07/21/22 Didi Global fined $1.2B by China after year-long probe, Bloomberg reports 07/19/22 China prepares to fine Didi over $1B over data breaches, Reuters says BHC Bausch Health $6.28 / +0.265 (+4.41%) 05/05/22 Bausch + Lomb seen pricing IPO at low end of expectations, WSJ says 04/13/22 Bausch Health probed by DOJ over dermatology drug marketing, STAT News says XOM VMW PCRX OXY IS HZNP ENDP BHC XOM Exxon Mobil $92.32 / -1.68 (-1.79%) 08/02/22 What You Missed On Wall Street On Tuesday 08/02/22 What You Missed On Wall Street This Morning 07/29/22 What You Missed On Wall Street On Friday 07/29/22 What You Missed On Wall Street This Morning VMW VMware $122.42 / +0.46 (+0.38%) 06/23/22 What You Missed On Wall Street This Morning 05/27/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/26/22 What You Missed On Wall Street On Thursday 05/26/22 What You Missed On Wall Street This Morning PCRX Pacira $57.77 / +0.4 (+0.70%) 07/14/22 What You Missed On Wall Street On Thursday 07/14/22 What You Missed On Wall Street This Morning 04/12/22 What You Missed On Wall Street On Tuesday 04/12/22 What You Missed On Wall Street This Morning OXY Occidental Petroleum $64.34 / -1.37 (-2.08%) 07/11/22 What You Missed On Wall Street On Monday 07/11/22 What You Missed On Wall Street This Morning 07/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/28/22 What You Missed On Wall Street On Tuesday IS ironSource $4.45 / +0.43 (+10.70%) 08/15/22 What You Missed On Wall Street On Monday 08/15/22 What You Missed On Wall Street This Morning 08/09/22 What You Missed On Wall Street On Tuesday 07/13/22 What You Missed On Wall Street On Wednesday HZNP Horizon Therapeutics $64.90 / -2.58 (-3.82%) 08/03/22 What You Missed On Wall Street On Wednesday 08/03/22 What You Missed On Wall Street This Morning 05/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/01/22 Fly Intel: Pre-market Movers ENDP Endo / + 07/12/22 What You Missed On Wall Street On Tuesday 07/01/22 Fly Intel: Pre-market Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning BHC Bausch Health $6.28 / +0.265 (+4.41%) 08/09/22 What You Missed On Wall Street This Morning 07/28/22 What You Missed On Wall Street On Thursday 07/28/22 What You Missed On Wall Street This Morning 08/21/22 Big Sky Technology Summit 08/29/22 Houston & Midland Texas Energy Bus(less) Tour XOM OXY OIH KWEB ENDP DIDIY BHC XOM Exxon Mobil $92.32 / -1.68 (-1.79%) 07/29/22 Early notable gainers among liquid option names on July 29th 06/10/22 Early notable gainers among liquid option names on June 10th 06/08/22 Notable open interest changes for June 8th 06/07/22 Early notable gainers among liquid option names on June 7th OXY Occidental Petroleum $64.34 / -1.37 (-2.08%) 08/09/22 Early notable gainers among liquid option names on August 9th 08/02/22 Occidental Petroleum options imply 5.5% move in share price post-earnings 07/13/22 Early notable gainers among liquid option names on July 13th OIH Oil Services Holders Trust $233.06 / -9.82 (-4.04%) 08/15/22 Unusually active option classes on open August 15th 04/25/22 Largest borrow rate increases among liquid names KWEB KraneShares CSI China Internet ETF $28.84 / +0.21 (+0.73%) 05/17/22 Unusually active option classes on open May 17th 04/29/22 Call sale in KraneShares China Internet ETF cashes out $1.2M three-day gain 04/29/22 Unusually active option classes on open April 29th 04/26/22 Unusually active option classes on open April 26th ENDP Endo / + 08/12/22 Largest borrow rate increases among liquid names 08/11/22 Largest borrow rate increases among liquid names 08/09/22 Endo options imply 43.5% move in share price post-earnings 08/08/22 Endo options imply 25.5% move in share price post-earnings DIDIY Didi Global $2.31 / + (+0.00%) 06/21/22 Largest borrow rate increases among liquid names 06/14/22 Notable open interest changes for June 14th 06/13/22 Two new option listings and two option delistings on June 13th BHC Bausch Health $6.28 / +0.265 (+4.41%) 08/10/22 Largest borrow rate increases among liquid names 08/05/22 Bausch Health call volume above normal and directionally bullish 07/27/22 Bausch Health put volume heavy and directionally bearish 07/22/22 Bausch Health call volume above normal and directionally bullish GLD GLD SPDR Gold Shares $165.73 / -2.14 (-1.27%) 04/22/22 On The Fly: ETF fund flow highlights 03/11/22 On The Fly: ETF fund flow highlights 03/04/22 On The Fly: ETF fund flow highlights 02/25/22 On The Fly: ETF fund flow highlights

Friday
Options	Largest borrow rate increases among liquid names » 08:45 08/12/22 08/12 08:45 08/12/22 08:45 WRBY Warby Parker $16.89 / +2.765 (+19.58%) , EXPI eXp World Holdings $17.75 / -0.035 (-0.20%) , NEGG Newegg Commerce $3.85 / + (+0.00%) , VTNR Vertex Energy $7.04 / -0.875 (-11.05%) , SAVA Cassava Sciences $19.85 / +0.03 (+0.15%) , BCAB BioAtla $7.95 / +1.26 (+18.83%) , AVDL Avadel Pharmaceuticals $6.85 / -0.27 (-3.79%) , DWAC Digital World Acquisition $30.34 / +0.07 (+0.23%) , ENDP Endo / + , CAN Canaan $4.08 / + (+0.00%) Latest data shows the… Latest data shows the largest indicative borrow rate increases among liquid option names include: Warby Parker (WRBY) 13.35% +2.28, eXp World Holdings (EXPI) 4.08% +0.90, Newegg Commerce (NEGG) 68.02% +0.75, Vertex Energy (VTNR) 5.67% +0.69, Cassava Sciences (SAVA) 42.09% +0.54, BioAtla (BCAB) 1.40% +0.29, Avadel Pharmaceuticals (AVDL) 12.01% +0.28, Digital World Acquisition Corp (DWAC) 50.81% +0.25, Endo (ENDP) 6.77% +0.20, and Canaan Inc (CAN) 1.22% +0.18. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options WRBY VTNR SAVA NEGG EXPI ENDP DWAC CAN AVDL WRBY Warby Parker $16.89 / +2.765 (+19.58%) 08/11/22 Warby Parker rises 19.3% 08/11/22 Warby Parker rises 19.9% 05/22/22 Fly Intel: Top five weekend stock stories 05/16/22 Warby Parker reports active customers increased 18.0% to 2.23M in Q1 VTNR Vertex Energy $7.04 / -0.875 (-11.05%) 08/09/22 Vertex Energy sees 2022 capex $115M-$120M 08/09/22 Vertex Energy sees Q3 total throughput 72,000-74,000 barrels per day at Mobile 06/14/22 Vertex Energy names James Rhame as COO, succeeding John Strickland 06/14/22 Vertex Energy appoints Alvaro Ruiz as chief strategy officer SAVA Cassava Sciences $19.85 / +0.03 (+0.15%) 08/03/22 Cassava Sciences expects results from CMS study of simufilam in 3Q23 08/03/22 Cassava says simufilam appears 'safe, well tolerated' in open-label study 08/03/22 Cassava expects topline results for open-label study of simufilam year-end 08/03/22 Cassava expects to initiate OLE study for Phase 3 simufilam program in 2H22 NEGG Newegg Commerce $3.85 / + (+0.00%) 05/12/22 Newegg Commerce shares insights about Newegg Live 05/09/22 Newegg Commerce enrolls as sole sponsor of hackIMSA 03/14/22 Newegg signs NCAA athlete endorsement deal with Carr Reese EXPI eXp World Holdings $17.75 / -0.035 (-0.20%) 08/04/22 eXp Realty appoints Patrick O'Neill as COO 07/14/22 eXp World Holdings completes acquisition of Zoocasa Realty 06/23/22 eXp World Holdings appoints Monica Weakley to board of directors 06/21/22 eXp World Holdings to acquire Zoocasa Realty ENDP Endo / + 08/09/22 Endo expects pre-arranged filing under Chapter 11 'imminently' 07/26/22 Buxton Helmsley sends letter to Endo directors relating to financial disclosures 07/18/22 Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer 07/15/22 Quoin Pharmaceuticals, Endo enter into exclusive distribution, supply agreement DWAC Digital World Acquisition $30.34 / +0.07 (+0.23%) 07/07/22 Truth Social denies Donald Trump left board of Trump Media 07/01/22 Trump Media & Technology Group says 'expanding and enhancing Truth Social' 06/27/22 Trump Media issues statement on Digital World Acquisition Corp. SEC filing 06/27/22 Digital World Acquisition says Garelick to resign from board CAN Canaan $4.08 / + (+0.00%) 06/23/22 Canaan repurchases over 4.72 million outstanding warrants for $6.6M 03/16/22 Canaan sees Q1 results impacted by quarantine control in China 03/16/22 Canaan announces $100M share repurchase program AVDL Avadel Pharmaceuticals $6.85 / -0.27 (-3.79%) 08/09/22 Avadel Pharmaceuticals sees cash runway to middle of 2023 07/19/22 Avadel Pharmaceuticals announces tentative FDA approval of LUMRYZ 06/29/22 Avadel Pharmaceuticals announces steps taken to accelerate FDA approval of FT218 06/03/22 Avadel Pharmaceuticals, AASM Foundation enter exclusive YIRF collaboration WRBY EXPI NEGG VTNR SAVA BCAB AVDL DWAC ENDP CAN WRBY Warby Parker $16.89 / +2.765 (+19.58%) 07/22/22 Piper Sandler Warby Parker initiated with an Overweight at Piper Sandler 07/21/22 Goldman Sachs Warby Parker price target lowered to $12 from $16 at Goldman Sachs 07/20/22 Stifel Warby Parker price target lowered to $11 from $15 at Stifel 06/27/22 Loop Capital Warby Parker price target lowered to $15 from $18 at Loop Capital EXPI eXp World Holdings $17.75 / -0.035 (-0.20%) 08/04/22 DA Davidson eXp World Holdings price target lowered to $22 from $28 at DA Davidson 05/05/22 DA Davidson eXp World Holdings price target lowered to $34 from $45 at DA Davidson NEGG Newegg Commerce $3.85 / + (+0.00%) VTNR Vertex Energy $7.04 / -0.875 (-11.05%) 08/10/22 Oppenheimer Vertex Energy downgraded to Perform from Outperform at Oppenheimer 08/10/22 H.C. Wainwright Vertex Energy price target lowered to $15 from $25 at H.C. Wainwright 07/07/22 Oppenheimer Vertex Energy initiated with an Outperform at Oppenheimer 06/08/22 Stifel Vertex Energy price target raised to $20 from $14 at Stifel SAVA Cassava Sciences $19.85 / +0.03 (+0.15%) 08/11/22 B. Riley Cassava Sciences price target lowered to $44 from $58 at B. Riley 06/02/22 Univest Securities Univest keeps Sell on Cassava after medical journal retracts article 05/06/22 Univest Securities Univest says Cassava enrollment still 'severely lags' others in Alzheimer's 05/06/22 B. Riley Cassava Sciences price target lowered to $58 from $72 at B. Riley BCAB BioAtla $7.95 / +1.26 (+18.83%) 08/10/22 H.C. Wainwright BioAtla price target lowered to $20 from $25 at H.C. Wainwright 05/05/22 Credit Suisse BioAtla downgraded to Neutral from Outperform at Credit Suisse 03/21/22 H.C. Wainwright BioAtla initiated with a Buy at H.C. Wainwright 10/14/21 BTIG BioAtla assumed with a Buy at BTIG AVDL Avadel Pharmaceuticals $6.85 / -0.27 (-3.79%) 08/11/22 SVB Securities Avadel Pharmaceuticals price target raised to $12 from $6 at SVB Securities 08/10/22 Jefferies Jefferies cuts Avadel to Hold while awaiting Lumryz full approval 08/09/22 Jefferies Avadel Pharmaceuticals downgraded to Hold from Buy at Jefferies 07/28/22 Craig-Hallum Avadel Pharmaceuticals assumed with a Buy at Craig-Hallum DWAC Digital World Acquisition $30.34 / +0.07 (+0.23%) ENDP Endo / + 05/09/22 BMO Capital Endo price target lowered to $2 from $4 at BMO Capital 05/09/22 Barclays Endo price target lowered to $1 from $2 at Barclays 05/06/22 Piper Sandler Piper downgrades Endo to sell, says 'going from bad to worse' 05/06/22 Piper Sandler Endo downgraded to Underweight from Neutral at Piper Sandler CAN Canaan $4.08 / + (+0.00%) 07/06/22 H.C. Wainwright Canaan initiated with a Buy at H.C. Wainwright 06/07/22 Benchmark Benchmark starts Canaan with Buy as 'indirect' bitcoin growth play 06/07/22 Benchmark Canaan initiated with a Buy at Benchmark 05/16/22 DA Davidson Canaan price target lowered to $10 from $15 at DA Davidson WRBY VTNR SAVA EXPI ENDP BCAB AVDL WRBY Warby Parker $16.89 / +2.765 (+19.58%) 08/11/22 Warby Parker lowers 2022 revenue view to $584M-$595M from $650M-$660M 08/11/22 Warby Parker reports Q2 EPS (28c) vs. (35c) a year ago 05/16/22 Warby Parker backs FY22 revenue view $650M-$660M, consensus $656.98M 05/16/22 Warby Parker reports Q1 adjusted EPS (30c), consensus 1c VTNR Vertex Energy $7.04 / -0.875 (-11.05%) 08/09/22 Vertex Energy reports Q2 EPS (98c) vs. (38c) last year 05/10/22 Vertex Energy sees FY23 adjusted EBITDA $425M-$450M 05/10/22 Vertex Energy sees FY22 adjusted EBITDA $340M-$360M 05/10/22 Vertex Energy reports Q1 EPS (8c), consensus (14c) SAVA Cassava Sciences $19.85 / +0.03 (+0.15%) 08/03/22 Cassava Sciences reports Q2 EPS (48c), consensus (43c) 05/05/22 Cassava Sciences reports Q1 EPS (44c), consensus (41c) EXPI eXp World Holdings $17.75 / -0.035 (-0.20%) 08/03/22 eXp World Holdings reports Q2 EPS 6c, consensus 19c 05/04/22 eXp World Holdings reports Q1 EPS 6c, consensus 1c 02/24/22 eXp World Holdings reports Q4 EPS 10c, consensus 7c ENDP Endo / + 08/09/22 Endo reports Q2 adjusted EPS (3c), consensus (14c) 05/05/22 Endo sees Q2 adjusted cont ops EPS (17c)-(15c), consensus 48c 05/05/22 Endo reports Q1 adjusted EPS 66c, consensus 44c 02/28/22 Endo sees Q1 EPS 35c-45c, consensus 48c BCAB BioAtla $7.95 / +1.26 (+18.83%) 08/09/22 BioAtla reports Q2 net loss $28.9M vs. $30.4M last year AVDL Avadel Pharmaceuticals $6.85 / -0.27 (-3.79%) 08/09/22 Avadel Pharmaceuticals reports Q2 EPS ($1.07), consensus (41c) 05/09/22 Avadel Pharmaceuticals reports Q1 EPS (45c), consensus (43c) 03/17/22 Avadel Pharmaceuticals reports Q4 EPS (38c), consensus (41c) 29 Sep WRBY SAVA EXPI ENDP DWAC WRBY Warby Parker $16.89 / +2.765 (+19.58%) 05/21/22 Robinhood among broken IPOs that could be buys, Barron's says SAVA Cassava Sciences $19.85 / +0.03 (+0.15%) 07/27/22 Justice Department opened criminal investigation into Cassava, Reuters says EXPI eXp World Holdings $17.75 / -0.035 (-0.20%) 04/07/22 Bear Cave's Dorsey sees 'problems' at eXp World Holdings ENDP Endo / + 07/12/22 Without an opioid deal, Endo moving toward bankruptcy filing, WSJ reports 06/30/22 Endo mulls bond decision amid bankruptcy considerations, Bloomberg reports DWAC Digital World Acquisition $30.34 / +0.07 (+0.23%) 07/07/22 Donald Trump left Trump Media board on June 8, Sarasota Herald-Tribune says 07/01/22 Digital World Acquisition subpoenaed by grand jury in Manhattan, CNBC says 05/06/22 Truth Social CEO says Trump 'encouraged' Musk to buy Twitter, NYP reports 04/20/22 Digital World Acquisition named as short idea by Kerrisdale Capital WRBY VTNR SAVA EXPI ENDP DWAC CAN AVDL WRBY Warby Parker $16.89 / +2.765 (+19.58%) 08/11/22 What You Missed On Wall Street On Thursday 08/11/22 What You Missed On Wall Street This Morning 08/11/22 Fly Intel: Pre-market Movers 07/29/22 Sell these stocks now, proven algorithm says VTNR Vertex Energy $7.04 / -0.875 (-11.05%) 08/09/22 What You Missed On Wall Street On Tuesday 08/09/22 What You Missed On Wall Street This Morning 07/09/22 Short Report: Carvana, Bed Bath Beyond short interest continues to grow 07/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SAVA Cassava Sciences $19.85 / +0.03 (+0.15%) 08/07/22 Short Report: Bed Bath Beyond in short-squeeze spotlight 07/27/22 What You Missed On Wall Street On Wednesday 07/27/22 What You Missed On Wall Street This Morning EXPI eXp World Holdings $17.75 / -0.035 (-0.20%) 04/07/22 What You Missed On Wall Street On Thursday 04/07/22 What You Missed On Wall Street This Morning ENDP Endo / + 07/12/22 What You Missed On Wall Street On Tuesday 07/01/22 Fly Intel: Pre-market Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning DWAC Digital World Acquisition $30.34 / +0.07 (+0.23%) 08/05/22 Sell these stocks now, proven algorithm says 07/06/22 #SocialStocks: Twitter and Indian government battle over blocking orders 06/27/22 What You Missed On Wall Street On Monday 06/27/22 What You Missed On Wall Street This Morning CAN Canaan $4.08 / + (+0.00%) 07/08/22 Here's What You Missed in Crypto This Week 06/10/22 Here's What You Missed in Crypto This Week 04/08/22 Here's What You Missed in Crypto This Week AVDL Avadel Pharmaceuticals $6.85 / -0.27 (-3.79%) 06/29/22 Fly Intel: After-Hours Movers 08:00 Today Canaan - CAN WRBY VTNR SAVA NEGG ENDP DWAC CAN AVDL WRBY Warby Parker $16.89 / +2.765 (+19.58%) 06/03/22 Largest borrow rate increases among liquid names 04/26/22 Largest borrow rate increases among liquid names 03/21/22 Largest borrow rate increases among liquid names VTNR Vertex Energy $7.04 / -0.875 (-11.05%) 08/02/22 Vertex Energy call volume above normal and directionally bullish 07/28/22 Vertex Energy call volume above normal and directionally bullish 07/15/22 Vertex Energy call volume above normal and directionally bullish 07/14/22 Vertex Energy call volume above normal and directionally bullish SAVA Cassava Sciences $19.85 / +0.03 (+0.15%) 08/02/22 Cassava Sciences call volume above normal and directionally bullish 06/29/22 Cassava Sciences put volume heavy and directionally bearish 06/10/22 Cassava Sciences call volume above normal and directionally bullish 06/06/22 Largest borrow rate increases among liquid names NEGG Newegg Commerce $3.85 / + (+0.00%) 08/04/22 Largest borrow rate increases among liquid names 07/11/22 Largest borrow rate increases among liquid names 06/22/22 Largest borrow rate increases among liquid names 04/22/22 Newegg Commerce call volume above normal and directionally bullish ENDP Endo / + 08/11/22 Largest borrow rate increases among liquid names 08/09/22 Endo options imply 43.5% move in share price post-earnings 08/08/22 Endo options imply 25.5% move in share price post-earnings 07/06/22 Largest borrow rate increases among liquid names DWAC Digital World Acquisition $30.34 / +0.07 (+0.23%) 08/10/22 Largest borrow rate increases among liquid names 08/08/22 Largest borrow rate increases among liquid names 07/14/22 Digital World Acquisition Corp call volume above normal and directionally bullish 07/11/22 Digital World Acquisition Corp call volume above normal and directionally bullish CAN Canaan $4.08 / + (+0.00%) 05/25/22 Largest borrow rate increases among liquid names 03/23/22 Canaan Inc call volume above normal and directionally bullish 03/22/22 Canaan Inc call volume above normal and directionally bullish 03/22/22 Unusually active option classes on open March 22nd AVDL Avadel Pharmaceuticals $6.85 / -0.27 (-3.79%) 06/09/22 Largest borrow rate increases among liquid names

Over a week ago
Options	Largest borrow rate increases among liquid names » 08:45 08/11/22 08/11 08:45 08/11/22 08:45 ISPO Inspirato $3.91 / -1.085 (-21.74%) , MVST Microvast $2.83 / +0.19 (+7.20%) , FFIE Faraday Future $2.58 / +0.09 (+3.61%) , TIGR UP Fintech $3.71 / +0.205 (+5.86%) , HYLN Hyliion Holdings $4.61 / +0.2 (+4.54%) , EVGO EVgo $10.60 / +1.33 (+14.35%) , ENDP Endo / + , YELL Yellow Corp $7.90 / +0.71 (+9.87%) , AMRS Amyris $3.25 / +0.965 (+42.23%) , CVNA Carvana $47.24 / +5.82 (+14.05%) Latest data shows the… Latest data shows the largest indicative borrow rate increases among liquid option names include: Inspirato (ISPO) 67.87% +16.69, Microvast Holdings (MVST) 12.79% +6.37, Faraday Future Intelligent Electric (FFIE) 6.66% +0.82, UP Fintech Holding Ltd (TIGR) 34.99% +0.64, Hyliion Holdings (HYLN) 1.93% +0.43, EVgo (EVGO) 42.02% +0.40, Endo (ENDP) 7.60% +0.33, Yellow Corp (YELL) 3.48% +0.29, Amyris (AMRS) 2.44% +0.28, and Carvana (CVNA) 1.29% +0.25. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options YELL MVST ISPO HYLN FFIE EVGO ENDP CVNA AMRS YELL Yellow Corp $7.90 / +0.71 (+9.87%) 07/20/22 Yellow Corp signs agreement with U.S. Army PaYS program 06/09/22 Yellow Corp reports quarter-to-date shipments per workday down 15.3% 04/22/22 Yellow Corp reaffirms commitment to reducing carbon footprint 03/10/22 Yellow Corp settles dispute with United States government MVST Microvast $2.83 / +0.19 (+7.20%) 06/27/22 Microvast joins Russell 3000 Index 05/12/22 TUV SUD supports Microvast in sustainable battery production 04/19/22 Microvast names Craig Webster as CFO 04/12/22 Microvast, China Automotive among new additions to SEC HFCAA provisional list ISPO Inspirato $3.91 / -1.085 (-21.74%) 06/09/22 Inspirato announces Inspirato Select subscription 04/21/22 Tang Capital reports 5.0% passive stake in Inspirato 04/18/22 Inspirato announces 11 new luxury residences at 71 Wentworth 04/11/22 Inspirato announces 2023 luxury cruise program HYLN Hyliion Holdings $4.61 / +0.2 (+4.54%) 07/25/22 Hyliion Holdings announces order from Ruan 06/28/22 Hyliion Holdings, Cummins to partner on natural gas engine optimization 03/08/22 Hyliion announces Cheri Lantz joined company as chief strategy officer 02/23/22 Hyliion Holdings says on track with Hypertruck ERX timeline FFIE Faraday Future $2.58 / +0.09 (+3.61%) 07/25/22 Faraday Future says needs additional funds to launch FF 91 06/27/22 FF Top Holding delivers notice of removal of Krolicki from Faraday Future board 04/07/22 Faraday Future receives noncompliance letter from Nasdaq 03/31/22 Faraday Future provides update on status of filings delay and investigation EVGO EVgo $10.60 / +1.33 (+14.35%) 08/11/22 EVgo enters new supply agreement with Delta Electronics 08/03/22 EVgo's PlugShare surpasses 5M check-ins 07/21/22 EVgo enters electrification partnership with Philadelphia 07/14/22 EVgo announces EVgo eXtend project to deploy 2,000 charging stalls ENDP Endo / + 08/09/22 Endo expects pre-arranged filing under Chapter 11 'imminently' 07/26/22 Buxton Helmsley sends letter to Endo directors relating to financial disclosures 07/18/22 Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer 07/15/22 Quoin Pharmaceuticals, Endo enter into exclusive distribution, supply agreement CVNA Carvana $47.24 / +5.82 (+14.05%) 08/05/22 Carvana rises 28.4% 08/05/22 Carvana trading resumes 08/05/22 Carvana trading halted, volatility trading pause 07/20/22 Carvana rises 14.6% AMRS Amyris $3.25 / +0.965 (+42.23%) 08/09/22 Amyris reaffirms FY22 consumer revenue view up 150% 06/23/22 Amyris begins fermentation at new plant in Barra Bonita, Brazil 04/11/22 Amyris begins commissioning of new fermentation plant in Barra Bonita, Brazil ISPO MVST FFIE TIGR HYLN EVGO ENDP YELL AMRS CVNA ISPO Inspirato $3.91 / -1.085 (-21.74%) 08/09/22 Cantor Fitzgerald Inspirato upgraded to Overweight from Neutral at Cantor Fitzgerald 08/08/22 Piper Sandler Inspirato price target lowered to $7 from $9 at Piper Sandler 07/22/22 Cantor Fitzgerald Inspirato assumed with a Neutral at Cantor Fitzgerald 06/28/22 Stifel Inspirato price target lowered to $6 from $7 at Stifel MVST Microvast $2.83 / +0.19 (+7.20%) 04/01/22 Morgan Stanley Microvast price target lowered to $4 from $6 at Morgan Stanley 12/17/21 Piper Sandler Microvast initiated with a Neutral at Piper Sandler FFIE Faraday Future $2.58 / +0.09 (+3.61%) 11/16/21 Wedbush Wedbush downgrades Faraday Future to Neutral, sees shares in 'penalty box' 11/16/21 Wedbush Faraday Future downgraded to Neutral from Outperform at Wedbush 10/25/21 Wedbush Hertz mega deal another 'feather in the cap' for Tesla, says Wedbush 08/17/21 Wedbush Wedbush bullish on Faraday Future, initiates with an Outperform TIGR UP Fintech $3.71 / +0.205 (+5.86%) 06/13/22 Daiwa UP Fintech price target raised to $5.70 from $5.40 at Daiwa 05/19/22 China Renaissance UP Fintech assumed with Hold from Buy at China Renaissance 12/01/21 Citi UP Fintech price target lowered to $7.58 from $18.22 at Citi 10/29/21 Alliance Global Partners MICT could benefit on top China brokers' fallout, says Alliance Global Partners HYLN Hyliion Holdings $4.61 / +0.2 (+4.54%) 08/11/22 Cantor Fitzgerald Hyliion Holdings downgraded to Neutral from Overweight at Cantor Fitzgerald 08/11/22 Cantor Fitzgerald Hyliion Holdings downgraded to Neutral from Overweight at Cantor Fitzgerald 06/21/22 JPMorgan Hyliion downgraded to Underweight on rising competition at JPMorgan 06/21/22 JPMorgan Hyliion Holdings downgraded to Underweight from Neutral at JPMorgan EVGO EVgo $10.60 / +1.33 (+14.35%) 07/07/22 Jefferies Jefferies starts EVgo at Hold, projects profitability by 2025 07/07/22 Jefferies EVgo initiated with a Hold at Jefferies 06/08/22 Capital One EVgo upgraded to Overweight from Equalweight at Capital One 05/16/22 Citi EVgo price target lowered to $10 from $11 at Citi ENDP Endo / + 05/09/22 BMO Capital Endo price target lowered to $2 from $4 at BMO Capital 05/09/22 Barclays Endo price target lowered to $1 from $2 at Barclays 05/06/22 Piper Sandler Piper downgrades Endo to sell, says 'going from bad to worse' 05/06/22 Piper Sandler Endo downgraded to Underweight from Neutral at Piper Sandler YELL Yellow Corp $7.90 / +0.71 (+9.87%) 01/04/22 Stephens Yellow Corp price target raised to $15 from $12 at Stephens 11/09/21 Stifel Yellow Corp price target raised to $13 from $7 at Stifel AMRS Amyris $3.25 / +0.965 (+42.23%) 08/10/22 Roth Capital Roth Capital downgrades Amyris to Neutral, lowers price target to $2 08/10/22 Roth Capital Amyris downgraded to Neutral from Buy at Roth Capital 06/24/22 JPMorgan Amyris initiated with a Neutral at JPMorgan 05/25/22 Piper Sandler Amyris initiated with a Neutral at Piper Sandler CVNA Carvana $47.24 / +5.82 (+14.05%) 08/08/22 Deutsche Bank Carvana price target lowered to $42 from $54 at Deutsche Bank 08/08/22 DA Davidson Carvana price target lowered to $42 from $49 at DA Davidson 08/08/22 JPMorgan Carvana downgraded to Underweight from Neutral at JPMorgan 08/05/22 BofA Carvana liquidity concerns easing as margins improve, says BofA YELL MVST ISPO HYLN FFIE EVGO ENDP CVNA AMRS YELL Yellow Corp $7.90 / +0.71 (+9.87%) 08/03/22 Yellow Corp reports Q2 EPS $1.17, consensus 45c 08/03/22 Yellow Corp reports Q2 EPS $1.17, consensus 45c 05/10/22 Yellow Corp reports Q1 EPS (54c), consensus (39c) MVST Microvast $2.83 / +0.19 (+7.20%) 05/16/22 Microvast backs FY22 revenue growth view of 35%-45% 05/16/22 Microvast reports Q1 EPS (15c) vs. (29c) last year 03/29/22 Microvast sees FY22 revenue growth of 35%-45% year-over-year 03/29/22 Microvast sees Q1 revenue $32M-$34M ISPO Inspirato $3.91 / -1.085 (-21.74%) 08/08/22 Inspirato reports Q2 EPS (6c) vs (1c) last year 05/11/22 Inspirato sees FY22 revenue $350M-$360M, consensus $354.13M 05/11/22 Inspirato reports Q1 EPS (26c), consensus (47c) HYLN Hyliion Holdings $4.61 / +0.2 (+4.54%) 08/09/22 Hyliion Holdings sees FY22 revenue $2M-$3M, consensus $2.4M 08/09/22 Hyliion Holdings reports Q2 EPS (19c), consensus (20c) 05/09/22 Hyliion Holdings reports Q1 EPS (19c), consensus (16c) 02/23/22 Hyliion Holdings reports Q4 EPS (17c), consensus (25c) FFIE Faraday Future $2.58 / +0.09 (+3.61%) 05/23/22 Faraday Future reports Q1 EPS (48c) , two estimates (19c) EVGO EVgo $10.60 / +1.33 (+14.35%) 08/09/22 EVgo backs FY22 revenue view $48M-$55M, consensus $50M 08/09/22 EVgo reports Q2 EPS 6c, consensus (17c) 05/11/22 EVgo sees 2022 revenue $48M-$55M, consensus $51.18M 05/11/22 EVgo reports Q1 EPS (21c), consensus (14c) ENDP Endo / + 08/09/22 Endo reports Q2 adjusted EPS (3c), consensus (14c) 05/05/22 Endo sees Q2 adjusted cont ops EPS (17c)-(15c), consensus 48c 05/05/22 Endo reports Q1 adjusted EPS 66c, consensus 44c 02/28/22 Endo sees Q1 EPS 35c-45c, consensus 48c CVNA Carvana $47.24 / +5.82 (+14.05%) 08/04/22 Carvana reports Q2 EPS ($2.35), consensus ($1.79) 08/04/22 Notable companies reporting after market close 04/20/22 Carvana no longer providing specific near-term guidance for the year 04/20/22 Carvana reports Q1 EPS ($2.89), consensus ($1.43) AMRS Amyris $3.25 / +0.965 (+42.23%) 08/09/22 Amyris reports Q2 GAAP EPS (34c), consensus (26c) 22 Apr EVGO ENDP CVNA EVGO EVgo $10.60 / +1.33 (+14.35%) 06/29/22 EVgo tells Reuters short-seller report contains 'inaccuracies,' 'outright lies' 06/29/22 Fuzzy Panda names 'broken ESG company' EVgo a short 06/29/22 EVgo named a short at Fuzzy Panda Research ENDP Endo / + 07/12/22 Without an opioid deal, Endo moving toward bankruptcy filing, WSJ reports 06/30/22 Endo mulls bond decision amid bankruptcy considerations, Bloomberg reports CVNA Carvana $47.24 / +5.82 (+14.05%) 07/01/22 Cohodes says LFI report points to 'major trouble at Carvana' 06/25/22 Carvana delivered undriveable cars, Barron's says 06/16/22 Partner behind big Carvana bet left Tiger Global, Bloomberg reports 05/11/22 Carvana laid off many employees over Zoom, Protocol reports YELL MVST ISPO HYLN FFIE EVGO ENDP CVNA AMRS YELL Yellow Corp $7.90 / +0.71 (+9.87%) 08/03/22 Fly Intel: After-Hours Movers MVST Microvast $2.83 / +0.19 (+7.20%) 03/30/22 Fly Intel: Pre-market Movers 03/29/22 Fly Intel: After-Hours Movers ISPO Inspirato $3.91 / -1.085 (-21.74%) 06/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/11/22 Fly Intel: After-Hours Movers 04/21/22 Fly Intel: After-Hours Movers HYLN Hyliion Holdings $4.61 / +0.2 (+4.54%) 06/21/22 What You Missed This Week in EVs and Clean Energy 06/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/07/22 What You May Have Missed This Week in EVs and Clean Energy 02/23/22 Fly Intel: After-Hours Movers FFIE Faraday Future $2.58 / +0.09 (+3.61%) 02/22/22 What You May Have Missed This Week in EVs and Clean Energy EVGO EVgo $10.60 / +1.33 (+14.35%) 07/25/22 Here's what Wall St. experts are saying about these automakers ahead of earnings 07/18/22 What You Missed This Week in EVs and Clean Energy 07/11/22 What You Missed This Week in EVs and Clean Energy 07/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations ENDP Endo / + 07/12/22 What You Missed On Wall Street On Tuesday 07/01/22 Fly Intel: Pre-market Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning CVNA Carvana $47.24 / +5.82 (+14.05%) 08/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/05/22 What You Missed On Wall Street On Friday 08/05/22 What You Missed On Wall Street This Morning 08/04/22 Fly Intel: After-Hours Movers AMRS Amyris $3.25 / +0.965 (+42.23%) 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 08/11/22 Microvast - MVST 08/12/22 Microvast Holdings Inc TIGR MVST ISPO FFIE EVGO ENDP CVNA AMRS TIGR UP Fintech $3.71 / +0.205 (+5.86%) 08/02/22 Largest borrow rate increases among liquid names 07/28/22 Largest borrow rate increases among liquid names 07/20/22 Unusually active option classes on open July 20th 07/18/22 Unusually active option classes on open July 18th MVST Microvast $2.83 / +0.19 (+7.20%) 03/29/22 Microvast Holdings options imply 9.0% move in share price post-earnings 03/24/22 Microvast Holdings put volume heavy and directionally bearish 03/17/22 Largest borrow rate increases among liquid names ISPO Inspirato $3.91 / -1.085 (-21.74%) 07/11/22 Largest borrow rate increases among liquid names 07/07/22 Largest borrow rate increases among liquid names 05/11/22 Inspirato options imply 7.9% move in share price post-earnings 05/11/22 Largest borrow rate increases among liquid names FFIE Faraday Future $2.58 / +0.09 (+3.61%) 07/26/22 Largest borrow rate increases among liquid names 07/11/22 Unusually active option classes on open July 11th 07/08/22 Faraday Future Intelligent Electric put volume heavy and directionally bearish EVGO EVgo $10.60 / +1.33 (+14.35%) 08/08/22 Largest borrow rate increases among liquid names 08/05/22 EVgo call volume above normal and directionally bullish 07/21/22 EVgo call volume above normal and directionally bullish 07/14/22 EVgo call volume above normal and directionally bullish ENDP Endo / + 08/09/22 Endo options imply 43.5% move in share price post-earnings 08/08/22 Endo options imply 25.5% move in share price post-earnings 07/06/22 Largest borrow rate increases among liquid names CVNA Carvana $47.24 / +5.82 (+14.05%) 08/08/22 Carvana call buyer realizes 96% same-day gains 08/04/22 Carvana options imply 16.6% move in share price post-earnings 07/27/22 Carvana call volume above normal and directionally bullish 06/30/22 Carvana put buyer realizes 5% same-day gains AMRS Amyris $3.25 / +0.965 (+42.23%) 08/10/22 Largest borrow rate increases among liquid names 08/09/22 Unusually active option classes on open August 9th 05/26/22 Unusually active option classes on open May 26th
Options	Endo options imply 43.5% move in share price post-earnings » 14:34 08/09/22 08/09 14:34 08/09/22 14:34 ENDP Endo / + Pre-earnings options… Pre-earnings options volume in Endo is 2.4x normal with calls leading puts :. Implied volatility suggests the market is anticipating a move near 43.5%, or 0c, after results are released. Median move over the past eight quarters is 13.5%. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ENDP Endo / + 08/09/22 Endo expects pre-arranged filing under Chapter 11 'imminently' 07/26/22 Buxton Helmsley sends letter to Endo directors relating to financial disclosures 07/18/22 Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer 07/15/22 Quoin Pharmaceuticals, Endo enter into exclusive distribution, supply agreement ENDP Endo / + 05/09/22 BMO Capital Endo price target lowered to $2 from $4 at BMO Capital 05/09/22 Barclays Endo price target lowered to $1 from $2 at Barclays 05/06/22 Piper Sandler Piper downgrades Endo to sell, says 'going from bad to worse' 05/06/22 Piper Sandler Endo downgraded to Underweight from Neutral at Piper Sandler ENDP Endo / + 08/09/22 Endo reports Q2 adjusted EPS (3c), consensus (14c) 05/05/22 Endo sees Q2 adjusted cont ops EPS (17c)-(15c), consensus 48c 05/05/22 Endo reports Q1 adjusted EPS 66c, consensus 44c 02/28/22 Endo sees Q1 EPS 35c-45c, consensus 48c ENDP Endo / + 07/12/22 Without an opioid deal, Endo moving toward bankruptcy filing, WSJ reports 06/30/22 Endo mulls bond decision amid bankruptcy considerations, Bloomberg reports ENDP Endo / + 07/12/22 What You Missed On Wall Street On Tuesday 07/01/22 Fly Intel: Pre-market Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning ENDP Endo / + 08/08/22 Endo options imply 25.5% move in share price post-earnings 07/06/22 Largest borrow rate increases among liquid names
Hot Stocks	Endo expects pre-arranged filing under Chapter 11 'imminently' » 08:55 08/09/22 08/09 08:55 08/09/22 08:55 ENDP Endo / + As of June 30, 2022, the… As of June 30, 2022, the company had approximately $1.2 billion in unrestricted cash; $8.1 billion of debt; and a net debt to adjusted EBITDA ratio of 5.6. These amounts reflect the company's payment of $35 million to acquire 6 sterile injectable product candidates and a $30 million upfront payment related to a Phase 3 injectable compound for the treatment of osteoarthritis knee pain. Second-quarter 2022 net cash used in operating activities was $133 million compared to $155 million provided by operating activities during the second-quarter 2021. This change was primarily attributable to decreased revenues. The company remains in constructive negotiations with an ad hoc group of first lien creditors, among other parties. In light of the progress to date, the company expects that these negotiations will likely result in a pre-arranged filing under Chapter 11 of the U.S. Bankruptcy Code by Endo International plc and substantially all of its subsidiaries, which could occur imminently. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ENDP Endo / + 07/26/22 Buxton Helmsley sends letter to Endo directors relating to financial disclosures 07/18/22 Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer 07/15/22 Quoin Pharmaceuticals, Endo enter into exclusive distribution, supply agreement 07/15/22 Endo, Quoin Pharmaceuticals partner on development of QRX003 in Canada ENDP Endo / + 05/09/22 BMO Capital Endo price target lowered to $2 from $4 at BMO Capital 05/09/22 Barclays Endo price target lowered to $1 from $2 at Barclays 05/06/22 Piper Sandler Piper downgrades Endo to sell, says 'going from bad to worse' 05/06/22 Piper Sandler Endo downgraded to Underweight from Neutral at Piper Sandler ENDP Endo / + 08/09/22 Endo reports Q2 adjusted EPS (3c), consensus (14c) 05/05/22 Endo sees Q2 adjusted cont ops EPS (17c)-(15c), consensus 48c 05/05/22 Endo reports Q1 adjusted EPS 66c, consensus 44c 02/28/22 Endo sees Q1 EPS 35c-45c, consensus 48c ENDP Endo / + 07/12/22 Without an opioid deal, Endo moving toward bankruptcy filing, WSJ reports 06/30/22 Endo mulls bond decision amid bankruptcy considerations, Bloomberg reports ENDP Endo / + 07/12/22 What You Missed On Wall Street On Tuesday 07/01/22 Fly Intel: Pre-market Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning ENDP Endo / + 08/08/22 Endo options imply 25.5% move in share price post-earnings 07/06/22 Largest borrow rate increases among liquid names
Earnings	Endo reports Q2 adjusted EPS (3c), consensus (14c) » 08:47 08/09/22 08/09 08:47 08/09/22 08:47 ENDP Endo / + Reports Q2 revenue… Reports Q2 revenue $569.11M, consensus $529.94M. As of June 30, the Company had approximately $1.2B in unrestricted cash; $8.1B of debt; and a net debt to adjusted EBITDA ratio of 5.6. These amounts reflect the Company's payment of $35M to acquire 6 sterile injectable product candidates and a $30M upfront payment related to a Phase 3 injectable compound for the treatment of osteoarthritis knee pain. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ENDP Endo / + 07/26/22 Buxton Helmsley sends letter to Endo directors relating to financial disclosures 07/18/22 Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer 07/15/22 Quoin Pharmaceuticals, Endo enter into exclusive distribution, supply agreement 07/15/22 Endo, Quoin Pharmaceuticals partner on development of QRX003 in Canada ENDP Endo / + 05/09/22 BMO Capital Endo price target lowered to $2 from $4 at BMO Capital 05/09/22 Barclays Endo price target lowered to $1 from $2 at Barclays 05/06/22 Piper Sandler Piper downgrades Endo to sell, says 'going from bad to worse' 05/06/22 Piper Sandler Endo downgraded to Underweight from Neutral at Piper Sandler ENDP Endo / + 05/05/22 Endo sees Q2 adjusted cont ops EPS (17c)-(15c), consensus 48c 05/05/22 Endo reports Q1 adjusted EPS 66c, consensus 44c 02/28/22 Endo sees Q1 EPS 35c-45c, consensus 48c 02/28/22 Endo reports Q4 EPS 84c, consensus 67c ENDP Endo / + 07/12/22 Without an opioid deal, Endo moving toward bankruptcy filing, WSJ reports 06/30/22 Endo mulls bond decision amid bankruptcy considerations, Bloomberg reports ENDP Endo / + 07/12/22 What You Missed On Wall Street On Tuesday 07/01/22 Fly Intel: Pre-market Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning ENDP Endo / + 08/08/22 Endo options imply 25.5% move in share price post-earnings 07/06/22 Largest borrow rate increases among liquid names
Options	Endo options imply 25.5% move in share price post-earnings » 15:11 08/08/22 08/08 15:11 08/08/22 15:11 ENDP Endo / + Pre-earnings options… Pre-earnings options volume in Endo is normal with calls leading puts 11:2. Implied volatility suggests the market is anticipating a move near 25.5%, or 0c, after results are released. Median move over the past eight quarters is 13.5%. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ENDP Endo / + 07/26/22 Buxton Helmsley sends letter to Endo directors relating to financial disclosures 07/18/22 Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer 07/15/22 Quoin Pharmaceuticals, Endo enter into exclusive distribution, supply agreement 07/15/22 Endo, Quoin Pharmaceuticals partner on development of QRX003 in Canada ENDP Endo / + 05/09/22 BMO Capital Endo price target lowered to $2 from $4 at BMO Capital 05/09/22 Barclays Endo price target lowered to $1 from $2 at Barclays 05/06/22 Piper Sandler Piper downgrades Endo to sell, says 'going from bad to worse' 05/06/22 Piper Sandler Endo downgraded to Underweight from Neutral at Piper Sandler ENDP Endo / + 05/05/22 Endo sees Q2 adjusted cont ops EPS (17c)-(15c), consensus 48c 05/05/22 Endo reports Q1 adjusted EPS 66c, consensus 44c 02/28/22 Endo sees Q1 EPS 35c-45c, consensus 48c 02/28/22 Endo reports Q4 EPS 84c, consensus 67c ENDP Endo / + 07/12/22 Without an opioid deal, Endo moving toward bankruptcy filing, WSJ reports 06/30/22 Endo mulls bond decision amid bankruptcy considerations, Bloomberg reports ENDP Endo / + 07/12/22 What You Missed On Wall Street On Tuesday 07/01/22 Fly Intel: Pre-market Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning ENDP Endo / + 07/06/22 Largest borrow rate increases among liquid names
Hot Stocks	Buxton Helmsley sends letter to Endo directors relating to financial disclosures » 06:11 07/26/22 07/26 06:11 07/26/22 06:11 ENDP Endo / + The Buxton Helmsley… The Buxton Helmsley Group, the New York City-based investment advisor to clients with financial interests in Endo International, issued an open letter to directors of the company and its financial auditor, PricewaterhouseCoopers LLP, relating to financial disclosures. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ENDP Endo / + 07/18/22 Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer 07/15/22 Quoin Pharmaceuticals, Endo enter into exclusive distribution, supply agreement 07/15/22 Endo, Quoin Pharmaceuticals partner on development of QRX003 in Canada 07/01/22 Endo receives Nasdaq notice of non-compliance ENDP Endo / + 05/09/22 BMO Capital Endo price target lowered to $2 from $4 at BMO Capital 05/09/22 Barclays Endo price target lowered to $1 from $2 at Barclays 05/06/22 Piper Sandler Piper downgrades Endo to sell, says 'going from bad to worse' 05/06/22 Piper Sandler Endo downgraded to Underweight from Neutral at Piper Sandler ENDP Endo / + 05/05/22 Endo sees Q2 adjusted cont ops EPS (17c)-(15c), consensus 48c 05/05/22 Endo reports Q1 adjusted EPS 66c, consensus 44c 02/28/22 Endo sees Q1 EPS 35c-45c, consensus 48c 02/28/22 Endo reports Q4 EPS 84c, consensus 67c ENDP Endo / + 07/12/22 Without an opioid deal, Endo moving toward bankruptcy filing, WSJ reports 06/30/22 Endo mulls bond decision amid bankruptcy considerations, Bloomberg reports ENDP Endo / + 07/12/22 What You Missed On Wall Street On Tuesday 07/01/22 Fly Intel: Pre-market Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning ENDP Endo / + 07/06/22 Largest borrow rate increases among liquid names

Over a month ago
Hot Stocks	Tiziana Life Sciences names Matthew Davis, MD, RPh as Chief Medical Officer » 06:04 07/18/22 07/18 06:04 07/18/22 06:04 TLSA Tiziana Life Sciences / + , ENDP Endo / + Tiziana Life Sciences… Tiziana Life Sciences (TLSA) announces that it has appointed Matthew Davis, MD, RPh as its Chief Medical Officer and Acting Chief Scientific Officer, effective immediately. Dr. Davis will report to Gabriele Cerrone, Executive Chairman and interim CEO of Tiziana. Dr. Davis previously served as Chief Scientific Officer and Chief Medical Officer at Endo Pharmaceuticals (ENDP) where he restructured the R&D department and collaborated to obtain BLA approval for QWO. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TLSA ENDP TLSA Tiziana Life Sciences / + 07/15/22 Tiziana Life Sciences announces resignation of CEO Dr. Kunwar Shailubhai 06/17/22 Tiziana Life Sciences receives Nasdaq deficiency notice 06/10/22 Tiziana Life Sciences announces purchase of common shares by chairman 06/09/22 Tiziana Life Sciences announces purchase of 18K common shares by chairman ENDP Endo / + 07/15/22 Quoin Pharmaceuticals, Endo enter into exclusive distribution, supply agreement 07/15/22 Endo, Quoin Pharmaceuticals partner on development of QRX003 in Canada 07/01/22 Endo receives Nasdaq notice of non-compliance 07/01/22 Endo reports jury verdict in favor of company in Opana ER antitrust trial TLSA ENDP TLSA Tiziana Life Sciences / + 06/13/22 ThinkEquity Tiziana Life Sciences initiated with a Buy at ThinkEquity 01/24/22 B. Riley Tiziana Life Sciences price target lowered to $3 from $8 at B. Riley ENDP Endo / + 05/09/22 BMO Capital Endo price target lowered to $2 from $4 at BMO Capital 05/09/22 Barclays Endo price target lowered to $1 from $2 at Barclays 05/06/22 Piper Sandler Piper downgrades Endo to sell, says 'going from bad to worse' 05/06/22 Piper Sandler Endo downgraded to Underweight from Neutral at Piper Sandler ENDP ENDP Endo / + 05/05/22 Endo sees Q2 adjusted cont ops EPS (17c)-(15c), consensus 48c 05/05/22 Endo reports Q1 adjusted EPS 66c, consensus 44c 02/28/22 Endo sees Q1 EPS 35c-45c, consensus 48c 02/28/22 Endo reports Q4 EPS 84c, consensus 67c ENDP ENDP Endo / + 07/12/22 Without an opioid deal, Endo moving toward bankruptcy filing, WSJ reports 06/30/22 Endo mulls bond decision amid bankruptcy considerations, Bloomberg reports ENDP ENDP Endo / + 07/12/22 What You Missed On Wall Street On Tuesday 07/01/22 Fly Intel: Pre-market Movers 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning ENDP ENDP Endo / + 07/06/22 Largest borrow rate increases among liquid names

On The Fly

News and insights, exclusive to thefly.com

18:23	Fly Intel: After-Hours Movers»
16:22	What You Missed On Wall Street On Thursday»
13:03	COVID vaccine makers under pressure as White House plans to end coverage»
12:54	Here's What You Missed in Cannabis This Week»
11:54	What You Missed On Wall Street This Morning»

View all On The Fly Stories »

Upcoming
Events (10)

RNST ...	Atlanta Bank Summit
MATW ...	August Virtual Micro Cap Conference
	Western Bank Summit
	Vaccine Virtual Forum
	Summer Workshop on Money, Banking, Payments & Finance
	4th Annual Virtual FinTech & Digital Transformation Conference
REGI ...	Energy Leaders Transition Summit
SPT	Sprout Social
NOVN	Novan
EVRI	Everi Holdings

View all of today’s events »

Today’s
Syndicate (3)

GCT	IPO
GFRX	Secondary
UBX	Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial